RTX
RTX
$179.30
-0.89%
RTX Corporation is a premier aerospace and defense manufacturer formed from the merger of United Technologies and Raytheon, operating across three core segments: Collins Aerospace (diversified aerospace supplier), Pratt & Whitney (commercial and military aircraft engines), and Raytheon (defense prime contractor for missiles, sensors, and communications). The company is a dominant market leader and a critical supplier to both commercial aerospace and global defense markets, with a massive scale and deep technological expertise. The current investor narrative is overwhelmingly driven by geopolitical tensions and proposed massive increases in U.S. defense spending, with recent headlines focused on a proposed $1.5 trillion military budget and commitments to quadruple production of advanced weaponry, positioning RTX as a primary beneficiary of a multi-year defense upcycle.…
RTX
RTX
$179.30
Related headlines
Investment Opinion: Should I buy RTX Today?
Rating & Thesis: Hold. RTX is a high-quality company riding powerful secular tailwinds, but its premium valuation and recent technical underperformance suggest the risk/reward is balanced at current levels, warranting patience for a better entry point. This aligns with the analyst consensus which is bullish but must be weighed against full valuation.
Supporting Evidence: The stock trades at a forward P/E of 26.07x based on estimated EPS of $9.20, a premium multiple that prices in strong growth. Revenue growth is accelerating (12.09% YoY in Q4), profitability is solid (ROE of 10.32%), and free cash flow generation is exceptional at $7.94 billion TTM. However, the trailing P/E of 36.54x is at a cyclical high, and the stock has underperformed the SPY by over 11% in the past month, indicating fading momentum.
Risks & Conditions: The two biggest risks are valuation compression and margin deterioration. This Hold rating would upgrade to a Buy if the forward P/E compressed toward 22x (offering a better margin of safety) or if the stock established strong support above $187 and showed renewed momentum. It would downgrade to a Sell if revenue growth decelerated below 8% or if net margins contracted below 6% for consecutive quarters. The stock is currently fairly valued to slightly overvalued relative to its own history, demanding flawless execution to justify further multiple expansion.
Sign up to view all
RTX 12-Month Price Forecast
RTX presents a classic 'great company, fully priced' scenario. The fundamental outlook is undeniably strong, backed by a transformative defense upcycle and robust financials. However, the market has aggressively priced in this optimism, leaving little margin for error. The neutral stance reflects the balance between a powerful long-term growth narrative and near-term valuation and momentum concerns. The stance would upgrade to bullish on a successful breakout above $214.5 with volume, confirming the resumption of the primary uptrend. It would turn bearish on a sustained break below the $187 support level, which would signal a failure of the current consolidation and potential for a deeper correction.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on RTX's 12-month outlook, with a consensus price target around $233.09 and implied upside of +30.0% versus the current price.
Average Target
$233.09
8 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
8
covering this stock
Price Range
$143 - $233
Analyst target range
Analyst coverage for RTX is robust, with 8 analysts providing estimates, indicating strong institutional interest. The consensus sentiment is bullish, reflected in recent institutional ratings which include actions like 'Buy', 'Overweight', and 'Outperform' from firms like Citigroup, JP Morgan, and RBC Capital, with only a few 'Neutral' stances. The average target price is not explicitly provided in the data, but analyst estimates point to an average EPS of $9.20 on revenue of $116.02 billion, which, when combined with the forward P/E context, suggests a positive outlook. The target price range has a low estimate of $8.99943 EPS and a high of $9.41116 EPS, indicating a relatively tight spread and thus higher conviction in the near-term earnings trajectory. The high target likely assumes successful execution on defense contract wins, sustained commercial aerospace recovery, and margin improvements, while the low target may factor in risks like execution missteps, supply chain issues, or political budget uncertainty. The pattern of recent ratings shows stability, with most firms reiterating their positive views, signaling sustained confidence in the company's fundamental story.
Bulls vs Bears: RTX Investment Factors
The bull case, driven by structural defense tailwinds and robust financials, currently holds stronger evidence, supported by accelerating revenue growth, massive free cash flow, and clear multi-year catalysts. However, the bear case presents significant near-term headwinds, primarily centered on valuation and momentum. The single most important tension in the investment debate is whether RTX's elevated valuation multiples (trailing P/E 36.54x) can be justified and sustained by the acceleration of earnings growth implied by the large gap to its forward P/E (26.07x). The resolution hinges on the company's ability to translate robust revenue growth into expanding, not contracting, profit margins in the coming quarters.
Bullish
- Strong Multi-Year Defense Tailwinds: Geopolitical tensions and proposed massive U.S. defense budget increases, including a $1.5 trillion proposal for 2027, create a structural, multi-year growth cycle for RTX's Raytheon segment. The company is a primary beneficiary of commitments to quadruple production of advanced weaponry, directly boosting its backlog and revenue visibility.
- Robust and Accelerating Revenue Growth: Q4 2025 revenue of $24.24 billion grew 12.09% YoY, building on a sequential quarterly increase from $20.31 billion in Q1 2025. This acceleration across all three segments (Collins, Pratt & Whitney, Raytheon) demonstrates the powerful combination of commercial aerospace recovery and surging defense demand.
- Exceptional Free Cash Flow Generation: The company generates substantial TTM free cash flow of $7.94 billion, providing ample internal funding for growth investments, dividends (53% payout ratio), and debt management. This strong cash generation underpins financial stability and shareholder returns even during capital-intensive periods.
- Solid Profitability and Balance Sheet: RTX maintains a healthy net margin of 6.69% (Q4 2025) and an ROE of 10.32%. The balance sheet is manageable with a debt-to-equity ratio of 0.61 and a current ratio of 1.03, indicating adequate liquidity and low financial risk.
Bearish
- Elevated Valuation Limits Upside: The trailing P/E of 36.54x sits near the upper end of its two-year historical range (19x-38x), suggesting much of the optimistic growth outlook is already priced in. The forward P/E of 26.07x, while lower, still represents a premium valuation, leaving limited room for multiple expansion and increasing sensitivity to earnings disappointments.
- Recent Margin Pressure and Earnings Volatility: Q4 2025 net income of $1.62 billion and net margin of 6.69% represent a sequential decline from Q3's $1.92 billion and 8.53% margin. Gross margin also dipped to 19.46% from 20.38%, indicating potential cost inflation or mix issues that could pressure profitability if sustained.
- Significant Recent Underperformance vs. Market: The stock has shown negative relative strength, down 3.98% over the past month and 2.72% over three months, while the SPY gained 7.36% and 2.67% respectively. This underperformance, despite strong fundamentals, signals potential profit-taking, sector rotation, or concerns about the pace of the rally.
- Political and Budget Execution Risk: While defense budgets are proposed to rise, they remain subject to political approval and execution. Rhetoric around NATO exit introduces long-term strategic uncertainty, and any delays or cuts to proposed spending could negatively impact the growth narrative and investor sentiment.
RTX Technical Analysis
The stock is in a sustained long-term uptrend, evidenced by a formidable 52.39% price increase over the past year. Currently trading at $196.42, it sits at approximately 74% of its 52-week range ($112.63 to $214.5), indicating it is positioned closer to the upper bound of its recent trading band, which reflects strong momentum but also suggests potential for consolidation after a significant run. Recent momentum, however, shows signs of deceleration and divergence from the long-term trend, with the stock down 3.98% over the past month and 2.72% over the past three months, contrasting sharply with the SPY's gains of 7.36% and 2.67% over the same periods, resulting in negative relative strength readings of -11.34 and -5.39, respectively. This underperformance signals a potential pause or pullback within the broader uptrend, possibly due to profit-taking or sector rotation. Key technical support is anchored near the 52-week low of $112.63, though more immediate support lies around the recent March lows near $187, while resistance is clearly defined at the 52-week high of $214.5. A breakout above $214.5 would signal a resumption of the primary bullish trend, whereas a breakdown below the $187 support could indicate a deeper correction. The stock's beta of 0.428 indicates it is significantly less volatile than the broader market, which is typical for a large-cap defense prime, suggesting more muted price swings during market turbulence.
Beta
0.43
0.43x market volatility
Max Drawdown
-16.1%
Largest decline past year
52-Week Range
$120-$215
Price range past year
Annual Return
+49.1%
Cumulative gain past year
| Period | RTX Return | S&P 500 |
|---|---|---|
| 1m | -7.6% | +8.5% |
| 3m | -8.5% | +2.8% |
| 6m | +0.4% | +4.6% |
| 1y | +49.1% | +32.3% |
| ytd | -4.2% | +3.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
RTX Fundamental Analysis
Revenue growth is robust and accelerating, with Q4 2025 revenue of $24.24 billion representing a 12.09% year-over-year increase, building on a multi-quarter trend of sequential growth from $20.31 billion in Q1 2025. The three segments—Collins Aerospace ($15.36B), Pratt & Whitney ($17.13B), and Raytheon ($14.66B)—are all contributing significantly, with the commercial aerospace recovery and defense demand providing dual tailwinds. The company is solidly profitable, with Q4 2025 net income of $1.62 billion and a net margin of 6.69%, though this represents a sequential decline from Q3's net income of $1.92 billion and net margin of 8.53%. Gross margin for Q4 was 19.46%, slightly down from 20.38% in Q3, indicating some potential margin pressure, but the operating margin remained healthy at 9.45%. The balance sheet and cash flow position is strong, with a manageable debt-to-equity ratio of 0.61 and a current ratio of 1.03, indicating adequate short-term liquidity. Most importantly, the company is generating substantial free cash flow, with TTM free cash flow of $7.94 billion, providing ample internal funding for growth, dividends (payout ratio of 53%), and debt management, as evidenced by the strong ROE of 10.32%.
Quarterly Revenue
$24.2B
2025-12
Revenue YoY Growth
+0.12%
YoY Comparison
Gross Margin
+0.19%
Latest Quarter
Free Cash Flow
$7.9B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is RTX Overvalued?
Given the positive net income, the primary valuation metric is the P/E ratio. The trailing P/E is elevated at 36.54x, while the forward P/E is significantly lower at 26.07x, based on estimated EPS of $9.20. This substantial gap implies the market is pricing in strong earnings growth expectations for the coming year. Compared to the Industrials sector, RTX's forward P/E of 26.07x trades at a premium; precise industry average data is not available in the provided set, but a forward multiple in the mid-20s is typical for high-quality defense primes with growth visibility. This premium is likely justified by the company's dominant market position and the clear, multi-year tailwind from rising defense budgets. Historically, the stock's own trailing P/E has ranged significantly, from lows near 19x in early 2024 to recent highs above 38x in late 2025. The current trailing P/E of 36.54x sits near the upper end of this two-year historical range, suggesting the market has already priced in a highly optimistic outlook for earnings growth and margin expansion, leaving limited room for multiple expansion and increasing sensitivity to any earnings disappointments.
PE
36.5x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range -26x~299x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
21.6x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: RTX faces margin pressure, as evidenced by the sequential decline in Q4 2025 net margin to 6.69% from 8.53% in Q3, alongside a dip in gross margin. While the balance sheet is strong with a 0.61 debt-to-equity ratio, earnings have shown volatility quarter-to-quarter. The company's valuation is highly dependent on continued high growth; a deceleration in the 12%+ revenue growth rate or failure to improve margins could trigger a significant de-rating given the premium trailing P/E of 36.54x.
Market & Competitive Risks: The primary market risk is valuation compression. The stock trades at a forward P/E of 26.07x, a premium to the broader Industrials sector, and its trailing P/E is at the high end of its own historical range. This makes it vulnerable to sector rotation out of defense or a broader compression in growth stock multiples. Geopolitical rhetoric, while a tailwind for budgets, also introduces headline volatility, as seen in news regarding NATO uncertainty. The stock's low beta of 0.428 suggests it is less correlated with market swings, but it may not participate fully in broad market rallies.
Worst-Case Scenario: The worst-case scenario involves a combination of defense budget delays, sustained margin compression, and a broader market de-rating of premium valuations. This could trigger analyst downgrades and a reversion toward the lower end of the historical P/E range. A realistic downside could see the stock fall to its recent key support near $187, representing a ~5% decline from current levels, or in a more severe scenario, test a level implied by a forward P/E in the low 20s, potentially implying a drop of 15-20%. The absolute floor is anchored by the 52-week low of $112.63, which would represent a catastrophic loss of over -40%, but this is viewed as highly improbable barring a fundamental business breakdown.
FAQ
The key risks are, in order of severity: 1) Valuation Risk: The high P/E multiples could compress if earnings growth slows or market sentiment shifts, leading to significant price depreciation. 2) Execution & Margin Risk: Sequential declines in net and gross margins in Q4 2025 must be monitored; persistent cost inflation or inefficiencies could erode profitability. 3) Political/Budget Risk: Proposed defense budget increases, while likely, are not guaranteed and could be delayed, reduced, or re-prioritized, impacting the growth narrative. 4) Geopolitical Sentiment Risk: While tensions drive demand, an unexpected de-escalation or change in administration policy could negatively affect investor sentiment toward defense stocks.
The 12-month forecast for RTX is a range-bound outlook with a bullish bias, centered on a base case target of $210-$225 (7-15% upside from $196.42). This assumes the company meets analyst consensus estimates of ~$9.20 EPS on ~$116B revenue, supported by rising defense budgets. The bull case (30% probability) targets $235-$250 if execution is flawless and budgets are swiftly approved. The bear case (15% probability) sees a pullback to $170-$187 if margins disappoint or budget momentum stalls. The most likely outcome is the base case, where earnings growth drives the stock higher but valuation limits explosive gains.
RTX appears fairly valued to slightly overvalued based on current metrics. Its trailing P/E of 36.54x is at the high end of its two-year historical range, indicating the market has priced in significant future growth. The forward P/E of 26.07x (based on $9.20 EPS) is more reasonable but still represents a premium to the broader market and many industrial peers. This premium is justified by the company's dominant market position and clear growth tailwinds, but it also implies that the stock is vulnerable to multiple compression if growth disappoints. The valuation is not egregious, but it leaves little room for error.
RTX is a good stock for investors with a long-term horizon who believe in the sustained defense upcycle and can accept current valuation levels. The stock offers a compelling growth story with 12% revenue growth and strong free cash flow, but it is not a clear-cut buy at this moment. The ~26x forward P/E is full, and the stock has recently underperformed the market. It would be a more attractive buy on a pullback toward the $187 support level, which would improve the risk/reward profile. For new money, a phased entry or waiting for a better technical setup is prudent.
RTX is predominantly suitable for a long-term investment horizon of 3-5 years. The core investment thesis is based on a multi-year defense procurement cycle and commercial aerospace recovery, which will take time to fully unfold. The stock's low beta of 0.428 indicates lower volatility relative to the market, making it less ideal for short-term trading based on technical swings. Furthermore, the current valuation suggests that near-term multiple expansion is limited, so returns will be more closely tied to earnings growth over time. Investors should be prepared to hold through potential political and budget-related volatility to capture the full value of the long-term growth story.